HBK Investments’s Exact Sciences EXAS Stock Holding History

HBK Investments’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-93,100	Closed	-$6.34M	–	204
2024 Q3	$6.34M	Sell	93,100 -68,200	-42%	-$3.85M	0.07%	92
2024 Q2	$6.81M	Buy	+161,300	New	+$8.88M	0.03%	78
2021 Q3	–	Sell	-17,000	Closed	-$2.11M	–	791
2021 Q2	$2.11M	Hold	17,000	–	–	0.01%	491
2021 Q1	$2.24M	Buy	+17,000	New	+$2.33M	0.01%	463

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

HBK Investments's EXAS Position: Q1 2026 in Review

HBK Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 7,646,637 shares — an estimated $777M sold.

HBK Investments first reported a position in EXAS in Q3 2013 and held it in 7 quarters. The position peaked at $777M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

HBK Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
HBK Investments sold 7,646,637 Exact Sciences shares in Q1 2026, an estimated $777M.
HBK Investments first reported a position in Exact Sciences in Q3 2013 and held it in 7 quarters.
HBK Investments's Exact Sciences position peaked at $777M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on HBK Investments's 13F filing for Q1 2026, filed 15 May 2026.